Early administration of vapreotide for variceal bleeding in patients with cirrhosis.
Eloubeidi
Mohamad A
MA
Arguedas
Miguel R
MR
D003131:Combined Modality Therapy; D004932:Esophageal and Gastric Varices / Q000150:complications* / Q000628:therapy; D005260:Female; D006471:Gastrointestinal Hemorrhage / Q000188:drug therapy* / Q000209:etiology; D006801:Humans; D008103:Liver Cirrhosis / Q000150:complications*; D008297:Male; D012008:Recurrence; D012307:Risk Factors; D013004:Somatostatin / Q000009:adverse effects / Q000031:analogs & derivatives / Q000627:therapeutic use*
C051458:vapreotide; D013004:Somatostatin